News | March 03, 2009

Many Patients Implanted with a LVAD ?Develop Right Ventricular Dysfunction?

March 3, 2009 - A recently published article in the Journal of Heart and Lung Transplantation (JHLT) from the German Heart Institute Berlin found right ventricular (RV) dysfunction develops in 20-50 percent of patients after left ventricular assist device (LVAD) implantation, leading to prolonged ICU stays and elevated mortality.

A second article, from the Hospital of the University of Pennsylvania (HUP), found that of 266 LVAD recipients, 99 required a RV assist device (37 percent).

“Right ventricular (RV) failure after left ventricular assist device (LVAD) placement is a serious complication and is difficult to predict,” the HUP article explained. “In the era of destination therapy and the total artificial heart, predicting post-LVAD RV failure requiring mechanical support is extremely important.”

“Right ventricular failure in LVAD patients is tragic,” said Dr. Jack Copeland, chief of cardiothoracic surgery at University Medical Center. “If it can be anticipated, the solution is biventricular support from the start. If it becomes a crisis, in appropriate patients, the CardioWest temporary total artificial heart may be life-saving. By replacing both sides of the dying heart, the CardioWest eliminates complications caused by failing ventricles, diseased valves, ventricle defects and electrical problems requiring a pacemaker and/or defibrillator.”

Both articles were published in the December 2008 issue of JHLT and presented at the 28th annual meeting of the International Society for Heart and Lung Transplantation (ISHLT) in April 2008.?

Originally designed as a permanent replacement heart, the CardioWest artificial heart is currently approved as a bridge to human heart transplant for patients dying from end stage biventricular failure.

The CardioWest artificial heart is the only FDA, Health Canada and CE mark approved total artificial heart in the world. There have been more than 780 implants of the CardioWest artificial heart, accounting for more than 150 patient years of life on the device.

For more information: www.SynCardia.com

Related Content

Transplanting Pig Hearts Into Humans One Step Closer
News | Cardiovascular Surgery | December 11, 2018
The scientific journal Nature recently published an article from Munich University Hospital which describes the long-...
Bilateral Artery Use Does Not Improve 10-Year CABG Outcomes
News | Cardiovascular Surgery | September 06, 2018
While it is firmly established that the use of one internal thoracic artery can improve life expectancy in coronary...
Mandatory Public Coronary Artery Bypass Grafting Reporting Associated With Better Patient Outcomes
News | Cardiovascular Surgery | April 30, 2018
Mandatory public reporting of coronary artery bypass grafting (CABG) results in Massachusetts was associated with...
Gecko Biomedical Receives CE Mark Approval for Setalum Sealant
News | Cardiovascular Surgery | September 19, 2017
Gecko Biomedical announced it has received CE Mark approval for its Setalum Sealant, allowing the company to market its...
ClearFlow Inc. Announces Positive U.S. Clinical Trial Results
News | Cardiovascular Surgery | September 08, 2017
September 8, 2017 — ClearFlow Inc.
Videos | Cardiovascular Surgery | July 19, 2017
This video educational session, provided in partnership with the American Society of Echocardiography (ASE), is title
Intensive Glycemic Control Program Produces Significant Per-Patient Cost Savings for CABG Surgery
News | Cardiovascular Surgery | May 25, 2017
A new study from Emory University observed a near-20 percent reduction in perioperative complications, a 1.2-day...
Risk of Heart Transplant Rejection Reduced by Desensitizing Patient Antibodies
News | Cardiovascular Surgery | May 23, 2017
The risk of heart transplant rejection can be reduced by desensitizing patient antibodies, according to research...
Scientists Show How Cells React to Injury From Open-Heart Surgery
News | Cardiovascular Surgery | May 04, 2017
Cedars-Sinai Heart Institute investigators have learned how cardiac muscle cells react to a certain type of injury that...
Overlay Init